SCHEMBL664039

SCHEMBL664039

CC(C)(C[C]=O)C[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9122760 0.85
SCHEMBL9860996 0.85
SCHEMBL5660517 0.85
SCHEMBL271229 0.83
SCHEMBL4196261 0.81
SCHEMBL6141425 0.81
SCHEMBL1410791 0.78
SCHEMBL9342 0.77
SCHEMBL4313929 0.76
SCHEMBL9821904 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3796900-A1 TRITERPENE AMINE DERIVATIVES DFH Therapeutics (US) 2021-03-31 EP claimed
CN-106967213-B Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance 厦门赛诺邦格生物科技股份有限公司 2019-11-05 CN claimed
CN-104725628-A Single functional branched polyethylene glycol containing degradable radical, preparation method and biorelevant substance of single functional branched polyethylene glycol XIAMEN SINOPEG BIOTECH CO LTD 2015-06-24 CN claimed
CN-104530415-A Hetero-functionalized Y-type polyethylene glycol derivative, preparation method and biologically related substance thereof XIAMEN SINOPEG BIOTECH INC 2015-04-22 CN claimed
CN-104530417-A Multifunctional H-type polyethylene glycol derivative and preparation method thereof XIAMEN SINOPEG BIOTECH INC 2015-04-22 CN claimed
CN-104530413-A Biologically related substances modified by multifunctional H-type polyethylene glycol derivative XIAMEN SINOPEG BIOTECH INC 2015-04-22 CN claimed
WO-2013056096-A1 POLYPEPTIDE-OPIOID CONJUGATES AND USES THEREOF ANGIOCHEM INC. (CA) 2013-04-18 WO claimed
US-20110144069-A1 COMPOUNDS FOR TREATING VIRAL INFECTIONS MYRIAD GENETICS, INCORPORATED (US) 2011-06-16 US claimed
JP-2011508748-A 2011-03-17 JP claimed
JP-2011508747-A 2011-03-17 JP claimed
US-20040248815-A1 Substituted amino acids as erythropoietin mimetics ORTHO MCNEIL PHARMACEUTICAL, INC. 2004-12-09 US claimed
EP-1073623-A4 SUBSTITUTED AMINO ACIDS AS ERYTHROPOIETIN MIMETICS ORTHO MCNEIL PHARM INC (US) 2004-08-18 EP claimed
EP-1255542-A1 SUBSTITUTED AMINO ACIDS AS NEUTRAL SPHINGOMYELINASE INHIBITORS Ortho-Mcneil Pharmaceutical, Inc. (US) 2002-11-13 EP claimed
US-20020016350-A1 Substituted amino acids as erythropoietin mimetics CONNOLLY PETER J (US) 2002-02-07 US claimed
US-6310078-B1 MODULATING ERYTHROPOIETIN RECEPTOR, TREATING DISEASE OR CONDITION MEDIATED BY SAID RECEPTOR ORTHO-MCNEIL PHARMACEUTICAL, INC. 2001-10-30 US claimed
US-6306911-B1 ENZYME INHIBITORS ORTHO-MCNEIL PHARMACEUTICAL, INC. 2001-10-23 US claimed
WO-2001056560-A1 SUBSTITUTED AMINO ACIDS AS NEUTRAL SPHINGOMYELINASE INHIBITORS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2001-08-09 WO claimed
EP-1073623-A1 SUBSTITUTED AMINO ACIDS AS ERYTHROPOIETIN MIMETICS Ortho-Mcneil Pharmaceutical, Inc. (US) 2001-02-07 EP claimed
WO-1999054279-A1 SUBSTITUTED AMINO ACIDS AS ERYTHROPOIETIN MIMETICS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 1999-10-28 WO claimed
WO-1989004672-A1 DERIVATIVES OF LINCOSAMINIDE ANTIBIOTICS THE UPJOHN COMPANY (US) 1989-06-01 WO claimed